Philippines

Resilience System

Main menu


You are here

Treatments

Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds

Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds

Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.

Scientists at the University of Texas Medical Branch, in a study published online Tuesday in Nature Medicine, found that the booster shots performed well against the BA.5 subvariant they were designed to target.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New study spotlights disparities in COVID-19 clinical trials

A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.

The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.570 seconds.